Oric Pharmaceuticals (ORIC) Interest & Investment Income (2020 - 2026)
Oric Pharmaceuticals (ORIC) posted Interest & Investment Income of -$1.1 million for Q1 2026, down 729.24% on a QoQ basis from $171000.0 in Q4 2025, and down 532.94% year-over-year from $248532.6 in Q1 2025.
Oric Pharmaceuticals (ORIC) Interest & Investment Income (2020 - 2026) Analysis & Trends
Oric Pharmaceuticals' Interest & Investment Income history runs 7 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- Quarterly Interest & Investment Income fell 532.94% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$499000.0 (down 234.5% YoY) and the FY2025 annual result came in at $407000.0, up 236.36% from the prior year.
- Interest & Investment Income was -$1.1 million for Q1 2026 at Oric Pharmaceuticals, down from $171000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $978000.0 in Q3 2024 and bottomed at -$1.1 million in Q1 2026.
- A 5-year average of -$11000.0 and a median of -$68000.0 in 2023 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 624.14% in 2022, while the deepest fall reached 10220.0% in 2022.
- Oric Pharmaceuticals' Interest & Investment Income stood at $456000.0 in 2022, then soared by 37.5% to $627000.0 in 2023, then tumbled by 154.7% to -$343000.0 in 2024, then soared by 149.85% to $171000.0 in 2025, then tumbled by 729.24% to -$1.1 million in 2026.
- Business Quant data shows ORIC's Interest & Investment Income at -$1.1 million in Q1 2026, $171000.0 in Q4 2025, and $428000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Oric Pharmaceuticals | 1.30 Bn | 1.30 Bn | - | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | 171,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Sep 30, 2024 | 978,000.00 |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -420,000.00 |
| Dec 31, 2023 | 627,000.00 |
| Sep 30, 2023 | 198,000.00 |
| Jun 30, 2023 | -68,000.00 |
| Mar 31, 2023 | 792,000.00 |
| Dec 31, 2022 | 456,000.00 |
| Sep 30, 2022 | -516,000.00 |
| Jun 30, 2022 | -429,000.00 |
| Mar 31, 2022 | -699,000.00 |
| Dec 31, 2021 | -87,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -14,000.00 |